IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Horizon Pharma Inc

CUSIP: 44047T959 | 3 institutional holders

Quarters

Q3 2014Q2 2014Q1 2014Q4 2013Q3 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile